GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
ACURA PHARMACEUTICAL (ACUR) [hlAlert]

Rating:
Buy ACUR
down 76.89 %

ACURA PHARMACEUTICAL (ACUR) rated Buy with price target $1 by ROTH Capital

Posted on: Friday,  Jan 9, 2015  2:25 PM ET by Roth Capital

Roth Capital rated Buy ACURA PHARMACEUTICAL (NASDAQ: ACUR) on 01/09/2015. Previously Roth Capital rated Buy ACURA PHARMACEUTICAL (NASDAQ: ACUR) on 05/14/2013.,
when the stock price was $2.38. Since then, ACURA PHARMACEUTICAL has lost 76.89% as of 01/15/2016's recent price of $0.55.
If you would have followed the previous Roth Capital's recommendation on ACUR, you would have lost 76.89% of your investment in 976 days.

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and manufacture of product candidates providing abuse deterrent features and benefits utilizing its Aversion Technology. The Company?s Aversion Technology platform has been successfully utilized in developing multiple opioid analgesic products candidates. Its portfolio of product candidates includes opioid analgesics to relieve pain while simultaneously discouraging common methods of pharmaceutical product misuse and abuse, including intravenous injection of dissolved tablets or capsules; nasal snorting of crushed tablets or capsules, and intentional swallowing of excess quantities of tablets or capsules. Acurox is an orally administered immediate release tablet containing oxycodone HCl as its sole active analgesic ingredient.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/9/2015 2:25 PM Buy
None
0.66 1.00
as of 8/27/2015
1 Week down  -11.29 %
1 Month down  -41.48 %
3 Months down  -28.57 %
1 YTD down  -67.06 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/14/2013 9:25 AM Buy
None
2.38

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy